Pfizer said new data shows its kid-sized COVID-19 booster could help healthy elementary-aged children rev up virus-fighting antibodies and plans to seek authorization soon.
Fox5 Atlanta's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
COVID-19 booster: Pfizer to seek extra shot for healthy kids 5 to 11
Pfizer said new data shows its kid-sized COVID-19 booster could help healthy elementary-aged children rev up virus-fighting antibodies and plans to seek authorization soon.
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
A booster dose of the Pfizer-BioNTech COVID-19 vaccine sparked a strong immune response in children ages 5 to 11, the companies jointly announced on Thursday.
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they…
Pfizer and BioNTech said Tuesday that they would ask the Food and Drug Administration (FDA) to authorize a booster dose of their coronavirus vaccine for emergency use in healthy kids ages 5 to 11.
A booster dose of the Pfizer COVID-19 vaccine raised antibody levels in children ages 5 to 11, according to the company, which said it plans to seek authorization for another shot for that age group. But what about those under the age of 5?
Citing a "robust response" of antibodies against Omicron in their vaccine trials, the companies said they were planning to submit a request "in the coming days."
Citing a "robust response" of antibodies against Omicron in their vaccine trials, the companies said they were planning to submit a request "in the coming days."
Pfizer and BioNTech said they would soon ask the Food and Drug Administration for emergency authorization of booster doses for that age group. Some residents in Beijing are stockpiling supplies after seeing reports of food shortages during a lockdown in Shanghai.
A booster shot of the coronavirus vaccine made by Pfizer-BioNTech increased the level of neutralizing antibodies against both the original version of the virus and the omicron variant in a small trial of children age 5 to 11, the companies announced Thursday.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
COVID-19 booster: Pfizer to seek extra shot for healthy kids 5 to 11 | Since Then
